Protective effect of antioxidants on blood oxidative stress caused by arginine

Fundamental and Clinical Pharmacology

Volumn 26, Issue 2, 2012, Pages 250-258

  de Lima, Daniela Delwing ^a   Delwing, Fábio ^b   da Cruz, José Geraldo Pereira ^c   Wyse, Angela Terezinha Souza ^d   Magro, Débora Delwing Dal ^c  

^a UNIVERSITY OF JOINVILLE REGION   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

tocopherol; Antioxidant enzymes; Arginine; Ascorbic acid; l NAME; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PREMEDICATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; TREATMENT DURATION;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; ARGININE; ASCORBIC ACID; CATALASE; ERYTHROCYTES; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; MALE; NG-NITROARGININE METHYL ESTER; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84858058826     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00909.x     Document Type: Article

References (57)

1. Brusilow S.W., Horwich A. Urea Cycle enzymes, Scriver C.R., Beaudet A.L., Sly W.S., Valle D. (Eds.), The metabolic and molecular bases of inherited disease, 8th edn, McGraw-Hill, New York, 2001, pp. 1909-1963.
2. Iyer R., Jenkinson C.P., Vockley J.G., Kern R.M., Grody W.W., Cederbaum S. The human arginases and arginase deficiency. J. Inherit. Metab. Dis. (1998) 21 86-100.
3. Flynn N.E., Meininger C.J., Haynes T.E., Wu G. The metabolic basis of arginine nutrition and pharmacotherapy. Biomed. Pharmacother. (2002) 56 427-438.
4. Alderton W.K., Cooper C.E., Knowles R. Nitric oxide synthases: structure, function and inhibition. Biochem. J. (2001) 357 593-615.
5. Dinerman J.L., Dawson T.M., Schell M.J., Snowman A., Snyder S.H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. Natl Acad. Sci. USA (1994) 91 4214-4218.
6. Dawson V.L., Dawson T.M. Nitric oxide in neuronal degeneration. Proc. Soc. Exp. Biol. Med. (1996) 211 33-40.
7. Lincoln J., Hoyle C.H.V., Burnstock G. Nitric oxide in health and disease. Biochem. Res. Topics, Cambridge University Press, Cambridge, 1997, pp. 3-11.
8. Rapoport R.M., Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cyclic GMP. Cir. Res. (1983) 52 352-357.
9. Battegay E.J. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J. Mol. Med. (1995) 73 333-346.
10. Beckman J.S., Carson M., Smith C.D., Koppenol W.H. ALS, SOD and peroxynitrite. Nature (1993) 364 584.
11. Lipton S.A., Choy Y.B., Pan Z.H. et al. A redox-based mechanism for the neuroprotective effects of nitric oxide and related nitroso-compounds. Nature (1993) 364 626-632.
12. White C.R., Brock T.A., Chang L.Y. et al. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl Acad. Sci. USA (1994) 91 1044-1048.
13. Heales S.J., Bolaños J.P., Stewart V.C., Brookes P.S., Land J.M., Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochem. Biophys. Acta. (1999) 1410 215-228.
14. Colome C., Sierra C., Vilaseca M.A. Congenital errors of metabolism: cause of oxidative stress? Méd. Clin. (2000) 115 111-117.
15. Wajner M., Latini A., Wyse A.T.S., Dutra-Filho C.S. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J. Inherit. Metab. Dis. (2004) 27 427-448.
16. Van Backel M.M., Printzen G., Wermuth B., Wiesmann U.N. Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am. J. Clin. Nutr. (2000) 72 976-981.
17. Artuch R., Colome C., Sierra C. et al. A longitudinal study of antioxidant status in phenylketonuric patients. Clin. Biochem. (2004) 37 198-203.
18. Delwing D., Delwing D., Wannamacher C.M.D., Wajner M., Dutra-Filho C.S., Wyse A.T.S. Arginine administration reduces catalase activity in midbrain of rats. Neuroreport (2002) 13 1301-1304.
19. +-ATPase activity in midbrain of rats subjected to arginine administration. Neurochem. Res. (2001) 26 515-520.
20. Delwing D., Delwing D., Bavaresco C.S., Wyse A.T.S. Protective effect of nitric synthase inhibition or antioxidants on brain oxidative damage caused by intracerebroventricular arginine administration. Brain Res. (2007) 1193 120-127.
21. +-ATPase inhibition induced by arginine administration is prevented by vitamins E and C. Neurochem. Res. (2003) 28 825-829.
22. Wyse A.T.S., Stefanello F.M., Chiarani F., Delwing D., Wannmacher C.M.D., Wajner M. Arginine administration decreases cerebral cortex acetylcholinesterase and serum butyrylcholinesterase probably by oxidative stress induction. Neurochem. Res. (2004) 29 385-389.
23. Delwing D., Gonçalves M.C.F., Sarkis J.J.F., Wyse A.T.S. L-NAME administration prevents the inhibition of nucleotide hydrolysis by rat blood serum subjected to hyperargininemia. Amino Acids (2005) 29 267-272.
24. Repetto M.G., Reides C.G., Evelson P., Kohan S., De Lustig E.S., Llesuy S.F. Peripheral markers of oxidative stress in probable Alzheimer patients. Eur. J. Clin. Invest. (1999) 29 643-649.
25. Buchmann I., Milakofsky L., Harris N., Hofford J.M., Vogel W.H. Effect of arginine administration on plasma and brain levels of arginine and various related amino compounds in the rat. Pharmacology (1996) 53 133-142.
26. Nishikawa T., Kirsch J.R., Koehler R.C., Bredt S.D., Snyder S.H., Traystman R.J. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Stroke (1993) 24 1718-1724.
27. +-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem. Res. (2002) 27 1685-1689.
28. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. (1979) 95 351-358.
29. Evelson P., Travacio M., Repetto M., Escobar J., Llesuy S., Lissi E.A. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch. Biochem. Biophys. (2001) 388 261-266.
30. Aebi H. Catalase in vitro. Methods Enzymol. (1984) 105 121-126.
31. Wendel A. Glutathione peroxidase. Meth. Enzymol. (1981) 77 325-332.
32. Marklund S.L. Pyrogallol autoxidation, Greenwald R.A. (Ed), Handbook for oxygen radical research, CRC press, Boca Raton, 1985, pp. 243-247.
33. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. (1951) 193 265-267.
34. Turpaev K.T. Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc) (2002) 67 281-292.
35. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging (2001) 18 685-716.
36. Delwing D., Cornélio A.R., Wajner M., Wannmacher C.M.D., Wyse A.T.S. Arginine administration reduces creatine kinase activity in rat cerebellum. Metab. Brain Dis. (2007) 22 13-23.
37. Delwing D., Tagliari B., Streck E.L., Wannamacher C.M.D., Wajner M., Wyse A.T.S. Reduction of energy metabolism in rat hippocampus by arginine administration. Brain Res. (2003) 983 58-63.
38. Delwing D., Tagliari B., Chiarani F., Wannmacher C.M.D., Wajner M., Wyse A.T.S. α-tocopherol and ascorbic acid administration prevents the impairment of brain energy metabolism of hyperargininemic rats. Cell. Mol. Neurobiol. (2006) 26 177-189.
39. +-ATPase activity and impairs retention of an inhibitory avoidance task in rats. Brain Res. (2002) 951 151-157.
40. Lissi E., Salim-Hanna M., Pascual C., Del Castillo M.D. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic. Biol. Med. (1995) 18 153-158.
41. Ghiselli A., Serafini M., Natella F., Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic. Biol. Med. (2000) 29 1106-1114.
42. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. (2004) 142 231-255.
43. Halliwell B., Gutteridge J.M.C. Oxygen radicals and nervous system. Trends Neurosci. (1985) 8 22-26.
44. Darley-Usmar V., Wiseman H., Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. (1995) 369 131-135.
45. Reznick A.Z., Packer L. Free radicals and antioxidants in muscular neurological diseases and disorders, Poli G., Albano E., Dianzani M.U. (Eds.), Free radicals: from basic science to medicine, Birkhauser Verlag, Basel, 1993, pp. 425-437.
46. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J. Neurochem. (2006) 97 1634-1658.
47. Halliwell B., Gutteridge J.M.C. Cellular responses to oxidative stress: adaptation, damage, repair, senescense and death, Halliwell B., Gutteridge J.M.C. (Eds.), Free radicals in biology and medicine, Oxford University Press, Oxford, 2007, pp. 187-267.
48. Van der Vliet A., Smith D., O'Neill C.A. et al. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem. J. (1994) 303 295-301.
49. Vasquez-Vivar J., Santos A.M., Junqueira V.B.C., Augusto O. Peroxynitrite-mediated formation of free radicals in human plasma: EPR detection of ascorbyl, albumin-thiyl, and puric acid derived free radicals. Biochem. J. (1996) 314 869-876.
50. Burton G.W., Wronska U., Stone L., Foster D.O., Ingold K.U. Biokinetics of dietary RRR-α-tocopherol in the male guinea-pig at three dietary levels of vitamin C and two levels of vitamin E. Lipids (1990) 25 199-210.
51. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine, Oxford University Press, London, 1999.
52. Sandy M.S., DiMonte D., Smith M.T. Relationships between intracellular vitamin E, lipid peroxidation, and chemical toxicity in hepatocytes. Toxicol. Appl. Pharmacol. (1988) 93 288-297.
53. Niki E. Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am. J. Clin. Nutr. (1991) 54 1119S-1124S.
54. McCay P.B. Vitamin E: interactions with free radical and ascorbate. Annu. Rev. Nutr. (1985) 5 323-340.
55. Frei B., Stocker R., England L., Ames B.N. Ascorbate: the most effective antioxidant in the blood. Adv. Exp. Med. Biol. (1990) 264 155-163.
56. Buettner G.R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. (1993) 300 535-543.
57. Carr A., Frei B. Does Vitamin C act as a pro-oxidant under physiological conditions? FASEB J. (1999) 13 1007-1024.